Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis

BMJ 2005; 330 doi: http://dx.doi.org/10.1136/bmj.330.7504.1366 (Published 9 June 2005)
Cite this as: BMJ 2005;330:1366

Related articles

News: High dose NSAIDs may double the risk of heart attacks and heart failure, says new study

Research: Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis

Research Methods & Reporting: Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes

News: Audit identifies the most read BMJ research papers

Letter: Life without COX 2 inhibitors: Risks and benefits are determined by dose and potency

This Week In the BMJ: NSAIDs may be cardiotoxic

Editorial: COX 2 inhibitors, traditional NSAIDs, and the heart

Editorial: Benefits and harms of drug treatments

Editorial: Efficacy and safety of COX 2 inhibitors

Editorial: Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?

Primary care: Antidepressants as risk factor for ischaemic heart disease: case-control study in primary care

Letter: Magnetic resonance imaging may be alternative to necropsy

This article has been cited by other articles: